Dual-Layer Rotation: A Versatile Therapeutic Mammoplasty Technique Sarianna JoukainenElina LaaksonenMazen Sudah Breast Oncology Open access 16 June 2022 Pages: 6716 - 6727
ASO Visual Abstract: Dual-Layer Rotation: A Versatile Therapeutic Mammoplasty Technique Sarianna JoukainenElina LaaksonenMazen Sudah ASO Visual Abstract 11 July 2022 Pages: 6728 - 6728
Access to Surgical Treatment for Breast Cancer in the Philippines Luis Miguel B. CoEdward Christopher DeeChristian Daniel U. Ang Breast Oncology 01 August 2022 Pages: 6729 - 6730
Impact of Three-Dimensional (3D) Visualization on Laparoscopic Hepatectomy for Hepatocellular Carcinoma Kin Pan AuMiu Yee ChanAlbert Chi Yan Chan Hepatobiliary Tumors 20 April 2022 Pages: 6731 - 6744
Impact of Preoperative CEA Uptrend on Survival Outcomes in Patients with Colorectal Liver Metastasis After Hepatectomy Yutaro HoriSatoru SeoEtsuro Hatano Hepatobiliary Tumors 12 June 2022 Pages: 6745 - 6754
ASO Author Reflections: CEA Uptrend is a Useful Biomarker to Predict Post-Hepatectomy Survival Outcomes in Patients with Colorectal Liver Metastasis Yutaro HoriSatoru Seo ASO Author Reflections 10 June 2022 Pages: 6755 - 6756
ASO Visual Abstract: Impact of Preoperative CEA Uptrend on Survival Outcomes in Patients with Colorectal Liver Metastasis after Hepatectomy Yutaro HoriSatoru SeoEtsuro Hatano ASO Visual Abstract 18 June 2022 Pages: 6757 - 6758
Does Caudate Resection Improve Outcomes of Patients Undergoing Curative Resection for Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis Richard W. D. GilbertTori LenetKimberly A. Bertens Hepatobiliary Tumors 15 June 2022 Pages: 6759 - 6771
ASO Visual Abstract: Does Caudate Resection Improve Outcomes inPatients Undergoing Curative Resection forPerihilar Cholangiocarcinoma? ASystematic Review and Meta-analysis Richard W. D. GilbertTori LenetKimberly A. Bertens ASO Visual Abstract 13 July 2022 Pages: 6772 - 6773
Application of a Convolutional Neural Network for Multitask Learning to Simultaneously Predict Microvascular Invasion and Vessels that Encapsulate Tumor Clusters in Hepatocellular Carcinoma Tongjia ChuChen ZhaoFeng Wei Hepatobiliary Tumors Open access 26 June 2022 Pages: 6774 - 6783
ASO Visual Abstract: Application of a Convolutional Neural Network for Multitask Learning to Simultaneously Predict Microvascular Invasion and Vessels That Encapsulate Tumor Clusters in Hepatocellular Carcinoma Tongjia ChuChen ZhaoFeng Wei ASO Visual Abstract 29 June 2022 Pages: 6784 - 6785
Radiomics-Based Preoperative Prediction of Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma Using Contrast-Enhanced Computed Tomography Shuaitong ZhangShengyu HuangJun Li Hepatobiliary Tumors 04 July 2022 Pages: 6786 - 6799
ASO Author Reflections: Radiomics-Based Strategy of Combining Conventional Clinico-Radiological Characteristics with Preoperative Prediction of Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma Jun LiShengyu HuangFeng Shen ASO Author Reflections 03 July 2022 Pages: 6800 - 6801
ASO Visual Abstract: Radiomics-Based Preoperative Prediction of Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma Using Contrast-Enhanced Computed Tomography Shuaitong ZhangShengyu HuangJun Li ASO Visual Abstract 16 July 2022 Pages: 6802 - 6803
Patterns of Caudate Lobe Invasion of Hilar Cholangiocarcinoma: A Panoramic Histologic Study of Liver Nan JiangSi-Yuan WangShuo Jin Hepatobiliary Tumors 08 July 2022 Pages: 6804 - 6812
ASO Author Reflections: Panoramic Histologic Patterns of Caudate Lobe Invasion in Hilar Cholangiocarcinoma Nan JiangCan-Hong XiangShuo Jin ASO Author Reflections 06 June 2022 Pages: 6813 - 6814
Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial Embolization: A Retrospective Study on Patterns, Treatments, and Prognoses Crisanta H. IlaganDebra A. GoldmanMichael I. D’Angelica Hepatobiliary Tumors 15 July 2022 Pages: 6815 - 6826
ASO Visual Abstract: Recurrence of Hepatocellular Carcinoma After Complete Radiologic Response to Trans-Arterial embolization: A Retrospective Study on Patterns, Treatments, and Prognosis Crisanta H. IlaganDebra A. GoldmanMichael I. D’Angelica ASO Visual Abstract 08 August 2022 Pages: 6827 - 6828
Long-Term Outcomes of Perioperative Versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases: An International Multicentre Propensity-Score Matched Analysis with Stratification by Contemporary Risk-Scoring Marcello Di MartinoFlorian PrimavesiElena MartĂn-PĂ©rez Hepatobiliary Tumors 18 July 2022 Pages: 6829 - 6842
ASO Author Reflections: Peri-operative Chemotherapy for Resectable Colorectal Liver Metastases Marcello Di MartinoFlorian Primavesi ASO Author Reflections 13 July 2022 Pages: 6843 - 6844
ASO Visual Abstract: Long-Term Outcomes of Perioperative versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases—An International Multicenter Propensity-Score Matched Analysis with Stratification by Contemporary Risk Scoring Marcello Di MartinoFlorian PrimavesiElena MartĂn-PĂ©rez ASO Visual Abstract 09 July 2022 Pages: 6845 - 6846
Automated Surgical-Phase Recognition for Robot-Assisted Minimally Invasive Esophagectomy Using Artificial Intelligence Masashi TakeuchiHirofumi KawakuboYuko Kitagawa Thoracic Oncology 28 June 2022 Pages: 6847 - 6855
ASO Author Reflections: Can Artificial Intelligence Evaluate the Surgical Learning Curve of Robot-Assisted Minimally Invasive Esophagectomy? Masashi TakeuchiHirofumi KawakuboYuko Kitagawa ASO Author Reflections 08 July 2022 Pages: 6856 - 6857
ASO Visual Abstract: Automated Surgical Phase Recognition for Robot-Assisted Minimally Invasive Esophagectomy Using Artificial Intelligence Masashi TakeuchiHirofumi KawakuboYuko Kitagawa ASO Visual Abstract 05 August 2022 Pages: 6858 - 6859
Albumin and Derived Neutrophil-to-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma Tomoki AbeTaro OshikiriYoshihiro Kakeji Thoracic Oncology 27 May 2022 Pages: 6860 - 6866
ASO Author Reflections: Decrease of Albumin and Derived Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy Reflect the Worse Prognosis in Patients with Esophageal Squamous Cell Carcinoma Tomoki AbeTaro OshikiriYoshihiro Kakeji ASO Author Reflections 26 May 2022 Pages: 6867 - 6868
ASO Visual Abstract: Albumin and Derived Neutrophil-To-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma Tomoki AbeTaro OshikiriYoshihiro Kakeji ASO Visual Abstract 28 June 2022 Pages: 6869 - 6870
Impact of Body Mass Index and Sarcopenia on Short- and Long-Term Outcomes After Esophageal Cancer Surgery: An Observational Study Go Wun KimJae-Sik NamIn-Cheol Choi Thoracic Oncology 27 May 2022 Pages: 6871 - 6881
ASO Author Reflections: Impact of Body Mass Index and Sarcopenia on Short- and Long-term Outcomes after Esophageal Cancer Surgery Go Wun KimJi-Hyun Chin ASO Author Reflections 06 June 2022 Pages: 6882 - 6883
ASO Visual Abstract: Impact of Body Mass Index and Sarcopenia on Short- and Long-Term Outcomes After Esophageal Cancer Surgery—An Observational Study Go Wun KimJae-Sik NamIn-Cheol Choi ASO Visual Abstract 13 July 2022 Pages: 6884 - 6885
Does Preoperative Corticosteroid Administration Improve the Short-Term Outcome of Minimally Invasive Esophagectomy for Esophageal Cancer? A Propensity Score-Matched Analysis Koshiro IshiyamaJunya OgumaHiroyuki Daiko Thoracic Oncology 03 June 2022 Pages: 6886 - 6893
Elevation of the Prognostic Factor Plasma Fibrinogen Reflects the Immunosuppressive Tumor Microenvironment in Esophageal Squamous Cell Carcinoma Shota HoshinoSatoru MatsudaYuko Kitagawa Thoracic Oncology 07 June 2022 Pages: 6894 - 6904
ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site? Shota HoshinoSatoru MatsudaYuko Kitagawa ASO Author Reflections 18 June 2022 Pages: 6905 - 6906
ASO Visual Abstract: Elevation of the Prognostic Factor Plasma Fibrinogen Reflects the Immunosuppressive Tumor Microenvironment in Esophageal Squamous Cell Carcinoma Shota HoshinoSatoru MatsudaYuko Kitagawa ASO Visual Abstract 18 June 2022 Pages: 6907 - 6908
Time to Incurable Recurrence for Patients Treated With Pulmonary Metastasectomy for Colorectal Cancer Haruhisa MatsugumaMingyon MunMasafumi Kawamura Thoracic Oncology 18 June 2022 Pages: 6909 - 6917
ASO Author Reflections: New Indicator to Demonstrate Cure Probability: Time to Incurable Recurrence Haruhisa MatsugumaMingyon MunMasafumi Kawamura ASO Author Reflections 21 May 2022 Pages: 6918 - 6919
ASO Visual Abstract: Time to Incurable Recurrence for Patients Who Receive Pulmonary Metastasectomy for Colorectal Cancer Haruhisa MatsugumaMingyon MunMasafumi Kawamura ASO Visual Abstract 04 July 2022 Pages: 6920 - 6921
Clinical Impact of Sarcopenia 1 Year After Surgery for Patients with Early-Stage Non-small Cell Lung Cancer Yuria UshitaniYoshihisa ShimadaNorihiko Ikeda Thoracic Oncology 21 June 2022 Pages: 6922 - 6931
ASO Author Reflections: Management to Prevent Postoperative Sarcopenia in Patients with Lung Cancer Yuria UshitaniYoshihisa Shimada ASO Author Reflections 14 June 2022 Pages: 6932 - 6933
ASO Visual Abstract: Clinical Impact of Sarcopenia 1 Year after Surgery in Patients with Early-Stage Non-small Cell Lung Cancer Yuria UshitaniYoshihisa ShimadaNorihiko Ikeda ASO Visual Abstract 28 June 2022 Pages: 6934 - 6935
Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms? Luis C. BorbonCatherine G. TranJames R. Howe Endocrine Tumors 08 July 2022 Pages: 6936 - 6946
ASO Visual Abstract: Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms? Luis C. BorbonCatherine G. TranJames R. Howe ASO Visual Abstract 18 July 2022 Pages: 6947 - 6948
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors Hallbera GudmundsdottirRon PerySean P. Cleary Endocrine Tumors Open access 22 June 2022 Pages: 6949 - 6957
ASO Author Reflections: Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors—A Single Operation is Feasible in Most Patients Hallbera GudmundsdottirThorvardur R. HalfdanarsonSean P. Cleary ASO Author Reflections 03 July 2022 Pages: 6958 - 6959
ASO Visual Abstract: Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors Hallbera GudmundsdottirRon PerySean P. Cleary ASO Visual Abstract Open access 18 July 2022 Pages: 6960 - 6961
Effect of Chemoradiotherapy on the Survival of Resectable Gastric Cancer Patients: A Systematic Review and Meta-Analysis Huiwen LuYimeng SunBaojun Huang Gastrointestinal Oncology 20 June 2022 Pages: 6962 - 6975
ASO Author Reflections: Chemoradiotherapy Versus Chemotherapy, Which One Is Better for Resectable Gastric Cancer Patients? Huiwen LuYimeng SunBaojun Huang ASO Author Reflections 10 June 2022 Pages: 6976 - 6977
ASO Visual Abstract: Effect of Chemoradiotherapy on the Survival of Resectable Gastric Cancer Patients—A Systemic Review and Meta-analysis Huiwen LuYimeng SunBaojun Huang ASO Visual Abstract 29 July 2022 Pages: 6978 - 6979
Management of Malignant Small Bowel Obstruction: Is Intestinal Bypass Effective Palliation? Meagan ReadBenjamin D. PowersSean P. Dineen Gastrointestinal Oncology 21 July 2022 Pages: 6980 - 6987
ASO Author Reflections: Bypassing the Problem: Approaches for the Treatment of Malignant Small Bowel Obstruction Meagan ReadBenjamin D. PowersSean P. Dineen ASO Author Reflections 28 July 2022 Pages: 6988 - 6989